pd168393 has been researched along with Lung Neoplasms in 3 studies
PD 168393 : A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmi, C | 1 |
| Cavazzoni, A | 1 |
| Vezzosi, S | 1 |
| Bordi, F | 1 |
| Vacondio, F | 1 |
| Silva, C | 1 |
| Rivara, S | 1 |
| Lodola, A | 1 |
| Alfieri, RR | 1 |
| La Monica, S | 1 |
| Galetti, M | 1 |
| Ardizzoni, A | 1 |
| Petronini, PG | 1 |
| Mor, M | 1 |
| Sos, ML | 2 |
| Rode, HB | 1 |
| Heynck, S | 1 |
| Peifer, M | 1 |
| Fischer, F | 1 |
| Klüter, S | 1 |
| Pawar, VG | 1 |
| Reuter, C | 1 |
| Heuckmann, JM | 1 |
| Weiss, J | 1 |
| Ruddigkeit, L | 1 |
| Rabiller, M | 1 |
| Koker, M | 1 |
| Simard, JR | 1 |
| Getlik, M | 1 |
| Yuza, Y | 1 |
| Chen, TH | 1 |
| Greulich, H | 1 |
| Thomas, RK | 2 |
| Rauh, D | 1 |
| Zander, T | 1 |
| Staratschek-Jox, A | 1 |
| Claasen, J | 1 |
| Wolf, J | 1 |
3 other studies available for pd168393 and Lung Neoplasms
| Article | Year |
|---|---|
Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion.
Topics: Aniline Compounds; Antineoplastic Agents; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Li | 2010 |
Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation.
Topics: Afatinib; Amino Acid Substitution; Animals; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell | 2010 |
Expression of signaling mediators downstream of EGF-receptor predict sensitivity to small molecule inhibitors directed against the EGF-receptor pathway.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chromones; Drug Resistance, Neoplasm; Drug Screeni | 2008 |